Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers
Part of paid clinical trials in Los Alamitos, California.
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study ID
- NCT07681076
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Healthy Volunteers
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- KarXT — DRUGSpecified dose on specified days
- Trimethobenzamide — DRUGSpecified dose on specified days
- Ondansetron — DRUGSpecified dose on specified days
- Meclizine — DRUGSpecified dose on specified days
Study Details
This study looks at how to reduce nausea and vomiting in people taking KarXT which is used to treat mental health conditions like schizophrenia. KarXT can cause stomach-related side effects, especially in the first couple of weeks. In this study, healthy volunteers will take KarXT along with anti-nausea medication, either regularly (to prevent symptoms) or as needed. The goal is to see how well these strategies help reduce nausea and vomiting and how safe the combination is. The results will help doctors better manage side effects and make treatment more comfortable for patients starting KarXT.
Key Dates
- First listed
- Jul 2, 2026
- Start date
- Sep 3, 2026
- Status verified
- Sep 2026
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 225 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Arm 1
- Experimental: Arm 2
- Experimental: Arm 3
- Experimental: Arm 4
Primary Outcome Measure
Number of participants with Treatment Emergent Adverse Events (TEAEs) [ Time Frame: Up to Day 21 ]
Central Contacts
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com855-907-3286
- First line of the email MUST contain NCT # and Site #.
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Collaborative Neuroscience Network - Los Alamitos- CenExel - PPDS | Los Alamitos | California | 90720 | David Walling, Site 0004 714-799-7799 |
| CenExel RCA - Hollywood | Hollywood | Florida | 33024-2639 | Edwin Gomez, Site 0002 954-604-3900 |
| Atlanta Center for Medical Research - CenExel ACMR - PPDS | Atlanta | Georgia | 30331 | Elyssa Barron, Site 0001 404-881-5800 |
| iResearch Atlanta - CenExel - PPDS | Decatur | Georgia | 30030 | Kimball Johnson, Site 0003 404-537-1281 |
Find similar trials in Los Alamitos, CA
Related Studies
- A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)PHASE1/PHASE2 · Recruiting · Regeneron Pharmaceuticals · Los Angeles, California
- A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell DiseasePHASE1/PHASE2 · Recruiting · Bristol-Myers Squibb · Birmingham, Alabama
- Blood Flow Restriction Training on Upper Extremity Grip StrengthRecruiting · Casa Colina Hospital and Centers for Healthcare · Pomona, California
- A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic HyperuricemiaPHASE1 · Recruiting · Novo Nordisk A/S · Glendale, California